Startup Somite AI announced today that it has raised over $47 million in a Series A funding round, bringing its total funding to about $60 million. The round was led by Khosla Ventures, with ...
BOSTON, Aug. 20, 2025 /PRNewswire/ -- Somite.ai, a company pioneering foundation models for human stem cells, today announced a strategic investment from AMD Ventures, following Somite's $47M Series A ...
[[To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the statement.]] "Receiving both Orphan Drug and Rare Pediatric Disease ...
BOSTON, May 13, 2025 /PRNewswire/ -- Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, ...
Hosted on MSN
Advanced Micro Devices (AMD): Somite.ai Announces Strategic Investment from AMD Ventures
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the Top Technology Stocks to Buy According to Hedge Funds. On August 20, Somite.ai announced a strategic investment from AMD Ventures, following the ...
Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Five scientists walked into a lab late last year and decided to ...
Somite Therapeutics Inc.’s lead program, SMT-M01, has been awarded orphan drug and rare pediatric disease designations by the FDA for the treatment of Duchenne muscular dystrophy (DMD). The program ...
During somitogenesis, presomitic mesoderm (PSM) can be divided into at least two distinct regions: region I (posterior PSM) and region II (anterior PSM), which correspond to the two distinct cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback